改良储药罐法联合甲钴胺片治疗腰椎间盘突出症寒湿痹阻证临床研究  

Clinical Study on Modified Medicine Storage Cupping Technique Combined with Mecobalamin Tablets in Treatment of Lumbar Disc Herniation with Cold-damp Obstruction Syndrome

作　　者：刘鸿雁 丁莹[1] 高春雨[1] 袁娜[1] 杨克新[1] 董永丽[1] 李路广 薛欢欢[1] 张椿燃 LIU Hongyan;DING Ying;GAO Chunyu;YUAN Na;YANG Kexin;DONG Yongli;LI Luguang;XUE Huanhuan;ZHANG Chunran(Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China)

机构地区：[1]中国中医科学院望京医院,北京100102

出　　处：《中国中医药信息杂志》2020年第12期10-14,共5页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：中国中医科学院望京医院院级科研课题(WJYY2018-11)。

摘　　要：目的观察改良储药罐法联合甲钴胺片治疗腰椎间盘突出症(LDH)寒湿痹阻证临床疗效。方法采用随机数字表法将80例患者分为治疗组和对照组各40例。2组均进行健康宣教,并予甲钴胺片,0.5 mg/次,3次/d,口服。在此基础上,治疗组采用改良储药罐法,对照组采用常规拔罐法,每3日1次。2组均连续治疗2周,随访1个月。比较2组临床疗效,观察2组治疗前后及随访时视觉模拟评分法(VAS)评分、日本骨科协会(JOA)评分,对2组进行安全性评价。结果治疗组、对照组分别脱落1、3例。治疗组总有效率为89.74%(35/39),对照组为78.38%(29/37),治疗组明显优于对照组(P<0.05)。与本组治疗前比较,2组治疗后VAS评分明显降低(P<0.05);与本组治疗后比较,治疗组随访时VAS评分明显降低(P<0.05);治疗组治疗后和随访时VAS评分均明显低于对照组(P<0.05)。与本组治疗前比较,2组治疗后JOA评分明显升高(P<0.05);与本组治疗后比较,治疗组随访时JOA评分明显升高(P<0.05);治疗组治疗后和随访时JOA评分明显高于对照组(P<0.05)。治疗组不良反应率为2.56%(1/39),对照组为5.41%(2/37),2组比较差异无统计学意义(P>0.05)。结论改良储药罐法联合甲钴胺片治疗LDH寒湿痹阻证临床疗效显著,可明显改善患者临床症状和腰椎功能。Objective To observe the clinical efficacy of modified medicine storage cupping technique combined with mecobalamin tablets in the treatment of lumbar disc herniation(LDH)with cold-dampness obstruction.Methods Totally 80 patients were randomly divided into treatment group(40 cases)and control group(40 cases).All patients were given health education,and mecobalamin tablets were given 0.5 mg each time,3 times a day,orally.On this basis,the treatment group was treated with modified medicine storage cupping method,and the control group was treated with routine cupping method,once every 3 days.Both groups were treated continuously for 2 weeks and followed up for 1 month.The clinical efficacy of the two groups was compared.The visual analogue score(VAS)and the score of the Japanese Orthopaedic Association(JOA)were observed before and after treatment and during the follow-up period.The safety of the two groups was evaluated.Results In the course of treatment,one case lost in the treatment group and three cases lost in the control group.The total effective rate was 89.74%(35/39)in the treatment group and 78.38%(29/37)in the control group(P<0.05).The total effective rate in the treatment group was significantly higher than that in the control group(P<0.05).Compared with before treatment,the VAS score of both groups decreased significantly after treatment(P<0.05).Compared with after treatment,the VAS score in the treatment group was significantly reduced during follow-up(P<0.05).The VAS score in the treatment group after treatment and during follow-up were significantly lower than the control group(P<0.05).Compared with before treatment,the JOA score of the two groups increased significantly after treatment(P<0.05).Compared with after treatment,the JOA score of the treatment group significantly increased during follow-up(P<0.05).The JOA score in the treatment group after treatment and during follow-up were significantly higher than the control group.The adverse reaction rate was 2.56%(1/39)in the treatment group and 5.41%(

关 键 词：改良储药罐 腰椎间盘突出症 寒湿痹阻证 

分 类 号：R274.915.33[医药卫生—中西医结合]